OncoVista Innovative Pink Sheet Forecast - Naive Prediction
| OVITDelisted Stock | USD 0.0001 0.00 0.00% |
The Naive Prediction forecasted value of OncoVista Innovative Therapies on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. OncoVista Pink Sheet Forecast is based on your current time horizon.
At this time the relative strength index (rsi) of OncoVista Innovative's share price is below 20 . This indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using OncoVista Innovative hype-based prediction, you can estimate the value of OncoVista Innovative Therapies from the perspective of OncoVista Innovative response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of OncoVista Innovative Therapies on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. OncoVista Innovative after-hype prediction price | USD 1.0E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
OncoVista |
OncoVista Innovative Additional Predictive Modules
Most predictive techniques to examine OncoVista price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for OncoVista using various technical indicators. When you analyze OncoVista charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
OncoVista Innovative Naive Prediction Price Forecast For the 24th of January
Given 90 days horizon, the Naive Prediction forecasted value of OncoVista Innovative Therapies on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict OncoVista Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that OncoVista Innovative's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
OncoVista Innovative Pink Sheet Forecast Pattern
| Backtest OncoVista Innovative | OncoVista Innovative Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of OncoVista Innovative pink sheet data series using in forecasting. Note that when a statistical model is used to represent OncoVista Innovative pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 30.385 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for OncoVista Innovative
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as OncoVista Innovative. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.OncoVista Innovative After-Hype Price Prediction Density Analysis
As far as predicting the price of OncoVista Innovative at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in OncoVista Innovative or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of OncoVista Innovative, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
OncoVista Innovative Estimiated After-Hype Price Volatility
In the context of predicting OncoVista Innovative's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on OncoVista Innovative's historical news coverage. OncoVista Innovative's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered OncoVista Innovative's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
OncoVista Innovative is very steady at this time. Analysis and calculation of next after-hype price of OncoVista Innovative is based on 3 months time horizon.
OncoVista Innovative Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as OncoVista Innovative is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading OncoVista Innovative backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with OncoVista Innovative, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 1 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0001 | 0.0001 | 0.00 |
|
OncoVista Innovative Hype Timeline
OncoVista Innovative is now traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. OncoVista is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on OncoVista Innovative is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company recorded a loss per share of 0.15. OncoVista Innovative had not issued any dividends in recent years. The entity had 1:1 split on the 29th of October 2007. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.OncoVista Innovative Related Hype Analysis
Having access to credible news sources related to OncoVista Innovative's direct competition is more important than ever and may enhance your ability to predict OncoVista Innovative's future price movements. Getting to know how OncoVista Innovative's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how OncoVista Innovative may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RGMP | Regnum Corp | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| COTQF | Cotinga Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FORU | ForU Holdings | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ANTH | Anthera Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NTII | Neurobiological Technologies | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LPTI | Longport | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NEWG | Greenwind Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SYVC | Synovics Pharmaceuticals | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PAOG | Pao Group | (0.0005) | 1 per month | 12.33 | 0.19 | 50.00 | (20.00) | 266.67 | |
| ONBI | ONE Bio Corp | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 150.00 |
OncoVista Innovative Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OncoVista Innovative pink sheet to make a market-neutral strategy. Peer analysis of OncoVista Innovative could also be used in its relative valuation, which is a method of valuing OncoVista Innovative by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
OncoVista Innovative Market Strength Events
Market strength indicators help investors to evaluate how OncoVista Innovative pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading OncoVista Innovative shares will generate the highest return on investment. By undertsting and applying OncoVista Innovative pink sheet market strength indicators, traders can identify OncoVista Innovative Therapies entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Story Coverage note for OncoVista Innovative
The number of cover stories for OncoVista Innovative depends on current market conditions and OncoVista Innovative's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that OncoVista Innovative is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about OncoVista Innovative's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in OncoVista Pink Sheet
If you are still planning to invest in OncoVista Innovative check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoVista Innovative's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |